Gilteritinib fumarate is the fumarate salt form of gilteritinib, an orally bioavailable inhibitor of receptor tyrosine kinases including FLT3, AXL, ALK, and LTK. It is used as an active pharmaceutical ingredient in manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1254053-84-3
Gilteritinib
pharmaceutical raw material
(6S)-rotigotine hydrochloride
pharmaceutical raw material
Ledipasvir
pharmaceutical raw material
N-[(S)-(4-Nitrophenoxy)phenoxyphosphinyl]-L-alanine 1-methylethyl ester
pharmaceutical raw material
Alectinib
pharmaceutical raw material
(E)-but-2-enedioic acid;bis(6-ethyl-3-[3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino]-5-(oxan-4-ylamino)pyrazine-2-carboxamide)
UJOUWHLYTQFUCU-WXXKFALUSA-N
CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5.CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5.C(=C/C(=O)O)\C(=O)O